|
TMBIM6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.581800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.400000E-01 |
| Normal-vs-Stage2 |
5.080000E-01 |
| Normal-vs-Stage3 |
3.905600E-02 |
| Normal-vs-Stage4 |
4.606400E-01 |
| Stage1-vs-Stage2 |
3.295400E-01 |
| Stage1-vs-Stage3 |
1.978110E-02 |
| Stage1-vs-Stage4 |
5.759200E-01 |
| Stage2-vs-Stage3 |
1.137680E-02 |
| Stage2-vs-Stage4 |
2.244400E-01 |
| Stage3-vs-Stage4 |
3.025600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.122600E-01 |
| Normal-vs-AfricanAmerican |
9.864600E-01 |
| Normal-vs-Asian |
6.417600E-01 |
| Caucasian-vs-AfricanAmerican |
5.809000E-01 |
| Caucasian-vs-Asian |
7.093200E-01 |
| AfricanAmerican-vs-Asian |
7.521600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.662800E-01 |
| Normal-vs-Female |
5.084400E-01 |
| Male-vs-Female |
8.135600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.063200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.813000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.752170E-01 |
| Normal-vs-Age(81-100Yrs) |
5.077600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.046400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.887230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.022200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.916000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.104800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.921000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.155910E-04 |
| Classical-VS-Follicular |
2.957600E-01 |
| Classical-VS-Other |
3.909400E-01 |
| Classical-VS-Normal |
7.248400E-01 |
| Tall-VS-Follicular |
1.574300E-04 |
| Tall-VS-Other |
4.430800E-01 |
| Tall-VS-Normal |
1.097140E-03 |
| Follicular-VS-Other |
3.103200E-01 |
| Follicular-VS-Normal |
5.427000E-01 |
| Other-VS-Normal |
2.618600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.819400E-01 |
| Normal-vs-N1 |
5.602300E-03 |
| N0-vs-N1 |
2.960500E-03 |
|
|
